Prescribing of medicinal cannabis in Australia has risen sharply since 2019. By the end of 2025, publicly available data from the Therapeutic Goods Administration shows close to one million approvals. That’s not just growth; that’s structural demand being built into the healthcare system.
But zoom out, and the real story gets bigger. Especially when you look at what is happening with ASX listed company Little Green Pharma (ASX:LGP).
Europe is a gateway to scale for Little Green Pharma
Entrepreneurs, investors and service providers in the medicinal cannabis market are all pushing into Europe and for good reason.
The region combines:
- Progressive regulatory tailwinds
- A rapidly scaling medical market
- And a population base nearly double that of the US and Canada combined
That’s a serious runway.
Little Green Pharma (ASX:LGP) boasts one of Europe’s largest medicinal cannabis production facilities…
Spanning 21,500m² in Denmark. Cannatrek, meanwhile, has built one of Australia’s leading portfolios of top-selling medicinal cannabis products.
Bring these two industry heavyweights together, and the potential scale, reach, and market impact is hard to ignore.
The data tells the story…
If you want proof of acceleration, look no further than Germany, Europe’s largest medical cannabis market.
According to BfArM:
- Q1 2024 imports: 8.143 tonnes
- Q1 2025 imports: 37.688 tonnes
- Q3 2025 imports: 56.915 tonnes
That’s not linear growth, that’s exponential demand. What a time for the LGP and Cannatrek merger!
While Europe scales, Australia is entering its next phase… consolidation.
Little Green Pharma has entered into a Scheme Implementation Deed to acquire Cannatrek Ltd via a scheme of arrangement.
This isn’t just another deal.
It represents:
- The combination of two of Australia’s largest and most established players
- The creation of one of the largest pure-play medicinal cannabis companies globally
- A clear move toward industry consolidation and market rationalisation
The Take Away
Medicinal cannabis is no longer an emerging story, it’s scaling globally.
With the upcoming merger of Little Green Pharma and Cannatrek, we will be watching the industry closely
